Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$337M |
| 2 |
Pfizer
PFE
|
+$315M |
| 3 |
Chevron
CVX
|
+$266M |
| 4 |
Procter & Gamble
PG
|
+$236M |
| 5 |
JPMorgan Chase
JPM
|
+$221M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Healthcare | 13.11% |
| 3 | Technology | 12.26% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYS
1401
DELISTED
CYS Investments Inc.
CYS
| $1.12M | ﹤0.01% |
+122,000
| New | +$1.37M |
|
|
PCP
1402
DELISTED
PRECISION CASTPARTS CORP
PCP
| $1.12M | ﹤0.01% |
+4,968
| New | +$1.01M |
|
|
STMP
1403
DELISTED
Stamps.com, Inc.
STMP
| $1.12M | ﹤0.01% |
+28,480
| New | +$951K |
|
|
ICPT
1404
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.12M | ﹤0.01% |
+25,000
| New | +$854K |
|
1405
Littelfuse
LFUS
$10.2B
| $1.12M | ﹤0.01% |
+15,000
| New | +$1.06M |
|
1406
Golar LNG
GLNG
$5.25B
| $1.12M | ﹤0.01% |
+35,008
| New | +$1.2M |
|
1407
Mine Safety
MSA
$7.29B
| $1.11M | ﹤0.01% |
+23,961
| New | +$1.15M |
|
1408
Tredegar Corp
TG
$278M
| $1.11M | ﹤0.01% |
+43,388
| New | +$1.16M |
|
|
PGNX
1409
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.11M | ﹤0.01% |
+250,000
| New | +$1.12M |
|
|
ATHN
1410
DELISTED
Athenahealth, Inc.
ATHN
| $1.11M | ﹤0.01% |
+13,131
| New | +$1.18M |
|
|
FINL
1411
DELISTED
Finish Line
FINL
| $1.11M | ﹤0.01% |
+50,892
| New | +$1.04M |
|
1412
AZZ Inc
AZZ
$4.23B
| $1.11M | ﹤0.01% |
+28,816
| New | +$1.24M |
|
1413
Clean Harbors
CLH
$16.6B
| $1.11M | ﹤0.01% |
+21,983
| New | +$1.23M |
|
1414
Bread Financial
BFH
$4.04B
| $1.11M | ﹤0.01% |
+7,685
| New | +$1.05M |
|
|
TXI
1415
DELISTED
TEXAS INDUSTRIES INC
TXI
| $1.11M | ﹤0.01% |
+17,011
| New | +$1.11M |
|
|
RTK
1416
DELISTED
Rentech, Inc.
RTK
| $1.1M | ﹤0.01% |
+52,503
| New | +$1.13M |
|
|
VRE
1417
DELISTED
Veris Residential
VRE
| $1.1M | ﹤0.01% |
+44,872
| New | +$1.2M |
|
1418
Steven Madden
SHOO
$3.36B
| $1.09M | ﹤0.01% |
+50,922
| New | +$1.07M |
|
1419
Agilent Technologies
A
$43.3B
| $1.09M | ﹤0.01% |
+35,768
| New | +$1.11M |
|
1420
Cirrus Logic
CRUS
$5.6B
| $1.09M | ﹤0.01% |
+62,995
| New | +$1.23M |
|
|
WRI
1421
DELISTED
Weingarten Realty Investors
WRI
| $1.09M | ﹤0.01% |
+35,436
| New | +$1.16M |
|
|
MCN
1422
Madison Covered Call & Equity Strategy Fund
MCN
$119M
| $1.09M | ﹤0.01% |
+137,018
| New | +$1.11M |
|
1423
Materion
MTRN
$4.79B
| $1.09M | ﹤0.01% |
+40,119
| New | +$1.13M |
|
|
MFA
1424
MFA Financial
MFA
$904M
| $1.08M | ﹤0.01% |
+32,104
| New | +$1.16M |
|
|
AAT
1425
American Assets Trust
AAT
$1.41B
| $1.08M | ﹤0.01% |
+35,093
| New | +$1.16M |
|
Similar funds
Cliff Asness's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cliff Asness, which disclosed 2,329 positions worth $28.2B. Its ten largest holdings account for 8.5% of the portfolio.
Its largest position is ExxonMobil: 3,744,346 shares worth $338M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Healthcare and Technology.
- Cliff Asness's largest Q2 2013 buy was ExxonMobil: 3,744,346 shares worth $338M.
- Cliff Asness's ten largest holdings make up 8.5% of its $28.2B portfolio in Q2 2013.
- Cliff Asness disclosed 2,329 positions in Q2 2013, its first 13F filing on record.
Based on AQR Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.